| Date Filed | Type | Description |
| 08/14/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/12/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 05/10/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on DMC Global Inc.|
Txns:
| Granted 7,086 shares
@ $0 |
|
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 4,610 shares
@ $0
Granted 22,750 options to buy
@ $4.88, valued at
$111k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,837 shares
@ $0
Granted 14,222 options to buy
@ $22.63, valued at
$321.8k
|
|
| 12/02/2020 |
3
| Kelly Michael Aaron (Director) has filed a Form 3 on AMICUS THERAPEUTICS, INC. |
| 10/23/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 5,754 shares
@ $0 |
|
| 09/29/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $22.65, valued at
$271.8k
|
|
| 09/29/2020 |
3
| Kelly Michael Aaron (Director) has filed a Form 3 on Aprea Therapeutics, Inc. |
| 08/03/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 1,782 shares
@ $0
Granted 2,223 options to buy
@ $37.53, valued at
$83.4k
|
|
| 07/28/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on DMC Global Inc.|
Txns:
| Granted 2,055 shares
@ $0 |
|
| 07/28/2020 |
3
| Kelly Michael Aaron (Director) has filed a Form 3 on DMC Global Inc. |
| 07/20/2020 |
3
| Kelly Michael Aaron (Director) has filed a Form 3 on NEOGENOMICS INC |
| 06/19/2020 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 9,600 options to buy
@ $11.45, valued at
$109.9k
|
|
| 04/24/2019 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 19,200 options to buy
@ $14, valued at
$268.8k
|
|
| 04/17/2019 |
3
| Kelly Michael Aaron (Director) has filed a Form 3 on HOOKIPA Pharma Inc. |